Anti-CCL2 (Carlumab) -VcMMAE
Product Specifications
Target
Microtubule Associated, CCR, Antibody-Drug Conjugates (ADCs), Apoptosis
Related Pathways
Microbiology/Virology, GPCR/G Protein, Apoptosis, Antibody-drug Conjugate/ADC Related, Immunology/Inflammation, Cytoskeletal Signaling
Bioactivity
Anti-CCL2 (Carlumab) -VcMMAE is an antibody-drug conjugate (ADC) composed of the human-derived anti-CCL2 antibody Carlumab, linked with valine-citrulline (vc) and tubulin inhibitor MMAE. The toxic moiety and linker in the ADC are McMMAE. Anti-CCL2 (Carlumab) -VcMMAE can induce apoptosis and is utilized in cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740218-100 1x 100 µL
CD100 (Semaphorin-4D) (A8), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680043-100 1x 100 µL
P21 / WAF1 (WA-1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040977-500 1x 500 µL
TGF-beta (1D11.16.8), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040889-100 1x 100 µL
PLAP (Placental Alkaline Phosphatase) (PL8-F6), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470014-500 1x 500 µL
CD31 / PECAM-1 (C31.7), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details